Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Early sexual development in children, especially girls, can be treated with hormone therapy to improve adult height and requires support for the child and family.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Plastic surgery has constantly evolved, improving patient care and expanding techniques, especially after the World Wars.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.